Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-blockers in hypertension.

L Hansson1

  • 1Department of Medicine, University of Gothenburg, Ostra Hospital, Sweden.

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|August 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

Lancet (London, England)·2000
Same author

Operations for extrahepatic bile duct cancers: are the results really improving?

The European journal of surgery = Acta chirurgica·2000
Same author

Blood pressure @ Internet-www.bloodpressure.nu.

Blood pressure·2000
Same author

Study on COgnition and Prognosis in the Elderly (SCOPE): baseline characteristics.

Blood pressure·2000
Same author

Endothelial dysfunction--a challenge for hypertension research.

Blood pressure·2000
Same author

Introduction: the role of combination therapy in modern antihypertensive therapy.

Journal of cardiovascular pharmacology·2000
Same journal

Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Hypertension and kidney alterations in rat offspring from low protein pregnancies.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Comparison of the effects of indapamide and captopril on the development of spontaneous hypertension.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

The protective effect of irbesartan in rats fed a high fat diet is associated with modification of leptin-adiponectin imbalance.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Chronic antioxidant therapy fails to ameliorate hypertension: potential mechanisms behind.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Endothelial dysfunction in spontaneously hypertensive rats: focus on methodological aspects.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
See all related articles

Beta-blockers are effective antihypertensive agents with a favorable efficacy-to-side effect balance. Emerging evidence suggests beta-blockers may offer primary prevention benefits for coronary heart disease in certain patients.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Beta-blockers, first observed for antihypertensive effects over two decades ago, are widely used for elevated arterial pressure.
  • Numerous beta-blocker compounds exist with varying ancillary properties, though beta 1-adrenoceptor blockade is key for blood pressure reduction.

Purpose of the Study:

  • To review the established role of beta-blockers in hypertension management and explore their potential primary preventive effects against coronary heart disease.
  • To assess the continued relevance of beta-blockers amidst newer therapeutic classes.

Main Methods:

  • Review of clinical observations and established therapeutic guidelines.
  • Analysis of existing data on beta-blocker efficacy, safety, and long-term clinical experience.
  • Examination of evidence regarding secondary and potential primary prevention of coronary heart disease.

Related Experiment Videos

Main Results:

  • Beta-blockers demonstrate a positive balance between efficacy and side effects, leading to their first-line status in many hypertension treatment guidelines.
  • Long-term clinical experience supports their use in hypertension and secondary prevention of coronary heart disease.
  • Preliminary data suggest potential primary preventive effects against coronary heart disease in specific patient subgroups.

Conclusions:

  • Beta-blockers remain a vital therapeutic option for hypertension due to their proven efficacy and safety profile.
  • Despite the emergence of newer drug classes, beta-blockers are expected to maintain a significant role in hypertension treatment.
  • Further research into the primary preventive cardiovascular benefits of beta-blockers is warranted.